FDA grants breakthrough status to Capitan Orthopedics’ SupraSpacer implant

The FDA has awarded a breakthrough device designation for Capitan Orthopedics' SupraSpacer implant for patients with irreparable rotator cuff tears. The implant functions by providing support within the joint, preventing the humerus from shifting upwards. The implant is designed for patients with irreparable rotator cuff injuries, particularly younger individuals. Credit: NMK-Studio / Shutterstock.com. Capitan Orthopedics has received breakthrough device designation from the US Food and Drug Administration (FDA) for its SupraSpacer implant, which provides a new treatment potential for patients with irreparable rotator cuff tears. More than two million individuals a year are currently diagnosed with rotator cuff injuries, and…

Source: Medical Device Network